The largest analysis to date of patients taking GLP-1 receptor agonists (GLP-1RAs) has investigated their effects on nearly 175 diseases, and found that compared to three other classes of diabetes ...
Immuron Ltd. has signed a new research collaboration agreement with Monash University to develop new therapeutic drug ...
In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...
It’s one thing for the scientific community to propose a fundamental change to the way obesity is defined and diagnosed. But ...
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award a seed grant of $610,000 to Justus ...
Corneal neovascularization (CNV) occurs when abnormal blood vessels grow into the cornea in response to ischemic or hypoxic ...
Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.
Having 35 copies of the CAG triplet in the gene that causes Huntington’s disease is not a problem. Inheriting 40 could be a ...
The U.K.’s Buckinghamshire NHS Trust has partnered medical technology design experts from Team Consulting Ltd. to create a tool that can transform burn care treatment. The concept training tool ...
As more Asia biotechs turn to regenerative medicine to address disorders without a cure, Medipost Inc. is continuing global ...
The EMA recommended the highest number of approvals in the last 15 years in 2024, giving the nod to 114 drugs. That is amongst the highest number in the 30 years of the agency’s existence, said ...
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback